Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Cornerstone Robotics Raises $68.2M in Series C to Advance Surgical Robots
CompanyDeals

Cornerstone Robotics Raises $68.2M in Series C to Advance Surgical Robots

January 14, 2025
MGI Tech's DNBSEQ-E25 Receives NMPA License as World's First Self-Luminescent Sequencer
CompanyMedical Device

MGI Tech’s DNBSEQ-E25 Receives NMPA License as World’s First Self-Luminescent Sequencer

January 14, 2025
Medtronic's BrainSense Technologies Win EU, UK CE Mark for Parkinson's Treatment
CompanyMedical Device

Medtronic’s BrainSense Technologies Win EU, UK CE Mark for Parkinson’s Treatment

January 14, 2025
Sansure Biotech to Acquire Sinobioway Hygene for $110M to Boost Product Pipeline
CompanyDeals

Sansure Biotech to Acquire Sinobioway Hygene for $110M to Boost Product Pipeline

January 14, 2025
Novo Nordisk Launches Rybelsus in China, World's First Oral GLP-1RA
CompanyDrug

Novo Nordisk Launches Rybelsus in China, World’s First Oral GLP-1RA

January 14, 2025
Merck's Keytruda Gains NMPA Approval for HNSCC Indication in China
CompanyDrug

Merck’s Keytruda Gains NMPA Approval for HNSCC Indication in China

January 14, 2025
Huadong Medicine Gets FDA Nod for Phase I Study of HDM2006 in Solid Tumors
CompanyDrug

Huadong Medicine Gets FDA Nod for Phase I Study of HDM2006 in Solid Tumors

January 14, 2025
Zhaoke Ophthalmology Partners with AFT for Brimochol PF Distribution in ANZ
CompanyDeals

Zhaoke Ophthalmology Partners with AFT for Brimochol PF Distribution in ANZ

January 14, 2025
Tonghua Dongbao Begins Phase II Trial for GLP-1/GIP Agonist THDBH120 in Weight Loss
CompanyDrug

Tonghua Dongbao Begins Phase II Trial for GLP-1/GIP Agonist THDBH120 in Weight Loss

January 14, 2025
Neo Modulus Secures $40.9M Series C Funding for Regenerative Medical Devices
CompanyDeals

Neo Modulus Secures $40.9M Series C Funding for Regenerative Medical Devices

January 14, 2025
MediLink Therapeutics and AstraZeneca Collaborate on YL201 and Imfinzi Combo for Solid Tumors
CompanyDeals

MediLink Therapeutics and AstraZeneca Collaborate on YL201 and Imfinzi Combo for Solid Tumors

January 14, 2025
Simcere Zaiming and AbbVie Ink $1.055B License Deal for MM Drug SIM0500
CompanyDeals

Simcere Zaiming and AbbVie Ink $1.055B License Deal for MM Drug SIM0500

January 14, 2025
1 2 … 273 274 275 276 277 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up